GDUFA Research Outcomes
OA Models
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to computational modeling of absorption for orally administered drugs to support generic product development and assessment.
-
How Might Excipients Impact Bioequivalence Assessments of Human Generic Drug Products
Wu, Fang
-
Using PBPK Model to Support Risk Assessment for Oral Products
Wu, Fang
-
Challenges and Opportunities when Using Oral PBPK to Support Risk Assessment and Biowaiver in Regulatory Submissions
Wu, Fang
-
Assessing Food Impact on Bioequivalence Using Physiologically-Based Pharmacokinetic Modeling
Wu, Fang
-
Bioequivalence Evaluation of Pediatric Products Using Physiologically Based Pharmacokinetic Modeling
Wu, Fang
-
PBPK Absorption Modeling to Support Risk Assessment and Biowaiver for Generic Oral Products
Wu, Fang
-
Using a Physiologically Based Pharmacokinetic Absorption Model to Establish Dissolution Bioequivalence Safe Space for Oseltamivir in Adult and Pediatric Populations
Wu, Fang
-
PBPK Absorption Modeling and Virtual Bioequivalence to Support Generic Drug Development and Regulatory Decision Making for Oral Products
Wu, Fang
-
Considerations for the Qualitative Sameness Evaluation of a Proposed Generic Formulation
Wang, Yan
-
Regulatory and Scientific Considerations on Characterizations of Complex Polymeric Excipients
Wang, Yan